VAERS Explorer
Back to explore

Report #2836144

Received Apr 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
Apr 4, 2025
Onset
Apr 4, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKY019464—

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

No side effects or symptoms have been reported.; 41-year-old female received a dose of PROQUAD; This spontaneous report was received from a medical assistant and refers to a 41-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-APR-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) Injection (lot #Y019464, expiration date: 24-MAY-2026) 0.5 mL as prophylaxis. The vaccine was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot # and expiration date was not provided) (inappropriate age at vaccine administration). No adverse event was reported.

Other medications

Sterile diluent